Walmart Inc. (FRA:WMT)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is February - January.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Market Capitalization	708,349	758,671	410,057	357,221	346,242	327,449
Market Cap Growth	53.30%	85.02%	14.79%	3.17%	5.74%	11.76%
Enterprise Value	765,088	816,287	471,056	416,657	391,641	377,658
Last Close Price	89.03	94.04	50.25	42.22	39.50	36.47
PE Ratio	42.70	40.57	28.68	33.22	28.36	29.42
PS Ratio	1.17	1.16	0.69	0.64	0.68	0.71
PB Ratio	8.87	8.07	4.91	4.62	4.22	4.54
P/TBV Ratio	14.63	13.66	8.61	8.77	7.84	8.45
P/FCF Ratio	-	62.29	29.42	32.38	35.02	15.40
P/OCF Ratio	-	21.64	12.45	13.45	16.04	11.02
EV/Sales Ratio	1.30	1.25	0.79	0.74	0.77	0.82
EV/EBITDA Ratio	19.30	20.10	13.15	12.76	11.99	13.60
EV/EBIT Ratio	30.23	29.01	18.92	18.45	16.91	20.33
EV/FCF Ratio	64.24	67.02	33.80	37.76	39.61	17.76
Debt / Equity Ratio	0.76	0.64	0.70	0.73	0.64	0.73
Debt / EBITDA Ratio	1.48	1.36	1.50	1.58	1.47	1.72
Debt / FCF Ratio	5.08	4.91	4.18	5.09	5.28	2.47
Asset Turnover	2.65	2.65	2.62	2.51	2.30	2.29
Inventory Turnover	9.12	9.19	8.79	8.20	8.46	9.40
Quick Ratio	0.19	0.20	0.20	0.18	0.26	0.26
Current Ratio	0.78	0.82	0.83	0.82	0.93	0.97
Return on Equity (ROE)	21.78%	21.41%	18.64%	12.84%	15.54%	16.21%
Return on Assets (ROA)	7.15%	7.12%	6.81%	6.28%	6.52%	5.76%
Return on Capital (ROIC)	11.75%	11.66%	11.30%	10.38%	10.76%	9.21%
Return on Capital Employed (ROCE)	18.50%	17.80%	16.90%	16.20%	16.50%	14.10%
Earnings Yield	2.34%	2.46%	3.49%	3.01%	3.53%	3.40%
FCF Yield	1.68%	1.60%	3.40%	3.09%	2.86%	6.49%
Dividend Yield	0.91%	0.85%	1.39%	1.63%	1.66%	1.63%
Payout Ratio	39.36%	34.41%	39.59%	52.35%	44.99%	45.27%
Buyback Yield / Dilution	0.35%	0.33%	1.15%	2.53%	1.47%	0.73%
Total Shareholder Return	1.26%	1.18%	2.54%	4.16%	3.13%	2.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.